December 20, 2012
The Food and Drug Administration (FDA) is requiring a black box warning on the Vertex Pharmaceuticals hepatitis C medication Incivek due to a potentially fatal skin rash. The FDA says that patients taking Incivek in combination with the medications ribavirin and interferon, which is taken by injection, should stop taking it immediately if they develop a rash that becomes worse or develops in tandem with other symptoms, such as fever, diarrhea, or mouth sores. The black box warning is the most serious form of safety warning available for medications.
12.19.2012; Associated Press
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Nurse-Led Program Bridges Gap Between HIV Diagnosis and Linkage to Care|
|Making HIV -- and Bias -- 'Part of the Party' to Strengthen Our Response to the Epidemic|
|Bias Is Everywhere: Uncovering HIV Prejudice to Improve Service Delivery|
|One Doc's Advice for Caring for Elderly Patients With HIV|
|Gene Therapy in HIV Cure Research|
|This Week in HIV Research: Looking Forward, Looking Back|